System Maintenance Notice

Please note that maintenance work is scheduled between 4 AM and 5 AM - CET. During this time, you may experience reduced performance. Thanks for your patience.

Borhane Annabi, PhD is an expert in Biochemistry at University of Quebec at Montreal (Canada). Borhane Annabi has authored 186 publications, the most recent in 2026. SLR score: 697 (community average: 125). How the SLR is computed.

LeadR Profile

Borhane Annabi, PhD University of Quebec at Montreal Canada
697 ScienceLeadR Reputation 697

Unlock

Register Login
Network Map

Biochemistry

Subspecialties: Oncology - Pharmacy - Immunology

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Organizations

Career arc: 1997 - 2026
Source: PubMed

Université du Québec à Montréal

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 186

Citations

Citations: 5 510 1st author: 28 Last author: 102 Unique author: 0

Main journals

Cancer Res 22
J Biol Chem 6
Cancers (Basel) 5
Biochem Biophys Res Commun 4
Mol Carcinog 4

Best Journals

Gastroenterology 1
J Clin Oncol 1

Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Advancing precision chemotherapy and overcoming resistance mechanisms through sortilin-directed peptide-drug conjugates.
PMID 42425329 — cells, microscopy, electron, scanning transmission, pharmaceutical preparations, neoplasms, stem cells, drug therapy, chemotherapy, sortilin		Crit Rev Oncol Hematol20260
Correction: Gresseau et al. A Signaling Crosstalk Links SNAIL to the 37/67 kDa Laminin-1 Receptor Ribosomal Protein SA and Regulates the Acquisition of a Cancer Stem Cell Molecular Signature in U87 Glioblastoma Neurospheres. Cancers 2022, 14, 5944.
PMID 42588748 — cells, microscopy, electron, scanning transmission, neoplasms, stem cells, glioblastoma, ribosomal proteins, laminin		Cancers (Basel)20260
The glucose-6-phosphatase system in cancer: from endoplasmic reticulum glucose-6-phosphate flux to stemness, immune escape, and therapeutic vulnerability.
PMID 42539452 — homeostasis, neoplasms, glucose-6-phosphatase, phosphoric monoester hydrolases, endoplasmic reticulum, therapeutics, glucose-6-phosphate		Front Oncol20260
Disrupting the TGF-β-regulated epithelial-mesenchymal transition, apoptotic and autophagic phenotypes of 3D glioblastoma spheroids via glycolytic inhibition.
PMID 42003977 — brain neoplasms, cells, genes, autophagy, epithelial-mesenchymal transition, brain, neoplasms, phenotype, glioblastoma, therapeutics, apoptosis		Explor Target Antitumor Ther20260
Targeting in vitro vasculogenic mimicry and associated stemness transcriptional signature in human ovarian cancer cell models: new emerging roles of caffeic acid phenethyl ester synthetic analogs.
PMID 41924141 — cells, microscopy, electron, scanning transmission, ovary, neoplasms, ketones, neoplasm metastasis, ovarian neoplasms, therapeutics, esters		Front Pharmacol20260

LeadR Networks

Main global connection map

Sources: PubMed, OpenAlex, ClinicalTrials, EU CTIS